{"id":"https://openalex.org/W2397836557","doi":null,"title":"Ezetimibe 5 and 10 mg for lowering LDL-C: potential billion-dollar savings with improved tolerability.","display_name":"Ezetimibe 5 and 10 mg for lowering LDL-C: potential billion-dollar savings with improved tolerability.","publication_year":2008,"publication_date":"2008-10-01","ids":{"openalex":"https://openalex.org/W2397836557","mag":"2397836557","pmid":"https://pubmed.ncbi.nlm.nih.gov/18837641"},"language":"en","primary_location":{"id":"pmid:18837641","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18837641","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of managed care","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091580801","display_name":"Lawrence Baruch","orcid":"https://orcid.org/0000-0002-9988-4883","observed_orcids":["https://orcid.org/0000-0002-9988-4883"]},"institutions":[{"id":"https://openalex.org/I4210116369","display_name":"James J. Peters VA Medical Center","ror":"https://ror.org/02c8hpe74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210094901","https://openalex.org/I4210116369"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lawrence Baruch","raw_affiliation_strings":["James J Peters VA Medical Center, Bronx, NY 10468, USA. lawrence.baruch@va.gov"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"James J Peters VA Medical Center, Bronx, NY 10468, USA. lawrence.baruch@va.gov","institution_ids":["https://openalex.org/I4210116369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065338305","display_name":"Bhanu P Gupta","orcid":"https://orcid.org/0000-0001-5113-6707","observed_orcids":["https://orcid.org/0000-0001-5113-6707"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bhanu Gupta","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083062330","display_name":"Sharon S. Lieberman-Blum","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sharon S Lieberman-Blum","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101414707","display_name":"Sanjay Agarwal","orcid":"https://orcid.org/0000-0002-6481-4340","observed_orcids":["https://orcid.org/0000-0002-6481-4340"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sanjay Agarwal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5009617151","display_name":"Calvin Eng","orcid":"https://orcid.org/0000-0002-0643-7495","observed_orcids":["https://orcid.org/0000-0002-0643-7495"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Calvin Eng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7063,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.74869765,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"14","issue":"10","first_page":"637","last_page":"41"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ezetimibe","display_name":"ezetimibe","score":1.0},{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.9100000262260437},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.7590000033378601},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.8970000147819519},{"id":"https://openalex.org/keywords/cost-reduction","display_name":"cost reduction","score":0.8140000104904175},{"id":"https://openalex.org/keywords/veterans","display_name":"veterans","score":0.6520000100135803},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.8109999895095825}],"concepts":[{"id":"https://openalex.org/C2778657065","wikidata":"https://www.wikidata.org/wiki/Q417997","display_name":"Ezetimibe","level":3,"score":0.9974102973937988},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8748000860214233},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7259572148323059},{"id":"https://openalex.org/C2778402494","wikidata":"https://www.wikidata.org/wiki/Q599756","display_name":"National Cholesterol Education Program","level":4,"score":0.6313683390617371},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6074239611625671},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.46006858348846436},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.44482195377349854},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4378899335861206},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.3724769055843353},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.34808963537216187},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.22224780917167664},{"id":"https://openalex.org/C2780578515","wikidata":"https://www.wikidata.org/wiki/Q657193","display_name":"Metabolic syndrome","level":3,"score":0.0646975040435791},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069059","descriptor_name":"Atorvastatin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069438","descriptor_name":"Ezetimibe","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001384","descriptor_name":"Azetidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001384","descriptor_name":"Azetidines","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D001384","descriptor_name":"Azetidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006538","descriptor_name":"Heptanoic Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006787","descriptor_name":"Hospitals, Veterans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:18837641","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18837641","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of managed care","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.979200005531311,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W752895202","https://openalex.org/W1969464487","https://openalex.org/W1998449668","https://openalex.org/W1998671622","https://openalex.org/W2029158612","https://openalex.org/W2089356907","https://openalex.org/W2106343349","https://openalex.org/W2120289695","https://openalex.org/W2125274568","https://openalex.org/W2134068835","https://openalex.org/W2140072878","https://openalex.org/W2163252871","https://openalex.org/W2169523655","https://openalex.org/W2331959986","https://openalex.org/W4249825849"],"related_works":["https://openalex.org/W2033123518","https://openalex.org/W2735934424","https://openalex.org/W2068583214","https://openalex.org/W1969923801","https://openalex.org/W2166289410","https://openalex.org/W2027595428","https://openalex.org/W2134068835","https://openalex.org/W2983573740","https://openalex.org/W1556011111","https://openalex.org/W1505590067"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"compare":[2],"the":[3,67,136,142],"clinical":[4],"efficacy":[5],"of":[6,66,75,82,108,147,175,212,219,230],"ezetimibe":[7,35,50,69,100,148,195,199],"5":[8,53,101,116,149,167,196],"mg":[9,117,152,161,168,197,201],"(prescribed":[10],"as":[11,56],"a":[12,19,57,226,233,238],"10-mg":[13,21,58,143],"tablet":[14,59],"split":[15,60],"in":[16,61,96,225,241],"half)":[17],"with":[18,205,237],"whole":[20],"tablet.":[22],"STUDY":[23],"DESIGN:":[24],"From":[25],"January":[26],"2003":[27],"through":[28],"July":[29],"2005,":[30,43],"all":[31,48,97,154],"Bronx":[32],"Veterans":[33],"Administration":[34],"prescriptions":[36,51],"were":[37,111,157,180],"for":[38],"10":[39,103,121,151,160,200],"mg.":[40,104,122],"In":[41],"August":[42],"it":[44],"was":[45,94],"mandated":[46],"that":[47,194],"new":[49],"be":[52],"mg,":[54],"prescribed":[55,99,112],"half.":[62],"METHODS:":[63],"The":[64,145,173],"impact":[65],"2":[68],"dosing":[70],"strategies":[71],"on":[72,153],"percent":[73],"lowering":[74],"low-density":[76],"lipoprotein":[77],"cholesterol":[78],"(LDL-C)":[79],"and":[80,118,131,139,150,185,198,210],"achievement":[81,211],"National":[83],"Cholesterol":[84],"Education":[85],"Program":[86],"Adult":[87],"Treatment":[88],"Panel":[89],"III":[90,214],"(ATP":[91],"III)":[92],"goals":[93],"assessed":[95],"patients":[98,110,176],"or":[102],"RESULTS:":[105],"A":[106],"total":[107],"272":[109,125],"ezetimibe;":[113],"86":[114],"received":[115,120],"186":[119],"Of":[123],"those":[124],"patients,":[126],"197":[127],"had":[128],"evaluable":[129],"baseline":[130],"posttreatment":[132],"LDL-C":[133,163,170,179,208,215],"(55":[134],"taking":[135,141],"5-mg":[137],"dose":[138],"142":[140],"dose).":[144],"effects":[146],"lipid":[155],"parameters":[156],"similar.":[158],"Ezetimibe":[159],"reduced":[162,169],"by":[164,171],"26.1%,":[165],"whereas":[166],"25.8%.":[172],"percentages":[174],"achieving":[177],"goal":[178],"similar:":[181],"61.8%":[182],"(5":[183],"mg)":[184],"60.5%":[186],"(10":[187],"mg).":[188],"CONCLUSION:":[189],"These":[190],"data":[191],"strongly":[192],"suggest":[193],"are":[202],"clinically":[203],"equivalent":[204],"respect":[206],"to":[207],"reduction":[209,240],"ATP":[213],"goals.":[216],"Widespread":[217],"adoption":[218],"this":[220],"low-dose":[221],"strategy":[222],"could":[223],"result":[224],"potential":[227,239],"cost":[228],"savings":[229],"more":[231],"than":[232],"billion":[234],"dollars":[235],"annually,":[236],"hepatotoxicity.":[242]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}